Testing effectiveness (Phase 2)Study completedNCT01434498
What this trial is testing
GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection
Who this might be right for
Chronic Genotype 1a or 1b HCV Infection
Gilead Sciences 163